‘We mapped the implementation status of HIVPrevention Combination in different countries.
Learn more about the implementation status of PrEP here.’

Bhutan   Cambodia   Indonesia   Nepal  Laos   Phillipines   Timor Leste   Pakistan   Sri Lanka

What is U=U?

The landmark research finding about people living with HIV (PLHIV) with undetectable viral load (virally suppressed) CANNOT pass on the virus through sexual transmission was based on HPTN, PARTNERS and PARTNERS2 Studies. Hence, the “Undetectable=Unstramittable (U=U)”. The PARTNERS2 Study, which is a ‘real-life’ study, showed that among the 77,000 condomless sexual acts among gay men and other men who have sex with men, there were ZERO transmission linked to their HIV positive partner. There is zero evidence that HIV transmission is actually possible with a suppressed viral load. The Center for Disease Control and Prevention (CDC) presented 100% effectiveness of Antiretroviral Therapy (ART) for people living with HIV to prevent sexual transmission. This also highlights that the ‘optimal use’ of ART (taking ART daily as prescribed and achieving and maintaining viral suppression) is an effective prevention strategy to reduce the risk of acquiring or transmitting HIV. This is achieved if people diagnosed positive for HIV is put into treatment as early as possible.

The messaging founded on the principle of U=U is vital for bringing the science to not only the general public and health practitioners, but also to people living with HIV who may not have been informed about U=U, especially those who are already marginalized by healthcare systems. From a human rights perspective, the campaign advocates for the rights of PLHIV to have access to accurate information about their social, sexual and reproductive health HIV stigma is a public health emergency and U=U can provide solution that can address stigma and discrimination.


Powered by: Supported by:



  • ---------------------------------------------------




    Underscore that combination HIV prevention is a cornerstone of an effective HIV response and includes the following evidence-based interventions dependent on national and regional epidemic characteristics: male and female condoms and lubricant, treatment as prevention, pre-exposure prophylaxis, post-exposure prophylaxis, voluntary medical male circumcision, harm reduction,15 in accordance with national legislation, comprehensive information and education, including in and out of school, screening and treatment of sexually transmitted infections, quality secondary education, economic empowerment, sexual and reproductive health, reducing risk-taking behaviour and encouraging safer sexual behaviour, including correct and consistent use of condoms, prevention of sexual and gender-based violence, poverty reduction and food security, and blood safety, and in this regard note with alarm the limited scale of combination prevention programmes


    Commend progress achieved in research, development and proven efficacy of innovative HIV interventions, including advances in treatment as prevention, pre-exposure prophylaxis, long-acting antiretrovirals for prevention and treatment, antiretroviral-based microbicides and other female-initiated options to reduce the risk of HIV infections, such as vaginal rings, and ongoing initiatives to define and address the threat of antimicrobial resistance in relation to HIV and associated diseases, comorbidities and coinfections, especially tuberculosis;

    Welcome the recent scientific evidence related to the preventative benefits of antiretroviral drug therapy, demonstrating no evidence of sexual transmission of HIV within adult couples when the HIV-positive partner is on effective and sustained treatment, with undetectable viral loads, confirmed by routine testing at intervals as recommended by the World Health Organization and reflected in its updated 2021 guidelines, which is known as “Undetectable = Untransmittable (U = U)”, also recognizing the continued need for further research;


    Commend the progress achieved in several regions of the world as a result of implementing research which has led to massive and rapid scaling-up of pre-exposure prophylaxis and the use of post-exposure prophylaxis, in conjunction with treatment as prevention, resulting in the rapid reductions in the number of new HIV infections


    Welcome that over 26 million people living with HIV are on antiretroviral therapy – a number that has more than tripled since 2010 – but note that, despite this progress, 12 million people living with HIV still do not have access to treatment, especially in Africa, and that these 12 million people are prevented from accessing treatment owing to inequalities, multiple and intersecting forms of discrimination and structural barriers.


    Note that viral hepatitis coinfection with HIV, including mortality due to viral hepatitis coinfection, is reported across populations at higher risk of HIV, especially among people who inject drugs;


    Note that people living with HIV are at substantially higher risk for many types of cancer, including those caused by the human papillomavirus, that women living with HIV are about six times more likely to develop cervical cancer and that anal cancer rates are substantially higher for men and women living with HIV than their HIV-negative peers.


    Recognize the resilience and innovation demonstrated by communities during the COVID-19 pandemic in reaching affected people with safe, affordable and effective services, including COVID-19 testing and vaccination, HIV prevention, testing and treatment and other health and social services;


    Express concern over the stagnation and decline in international resources for the HIV response, reaffirm the importance of international public finance as a complement to domestic resources, reiterate that the fulfilment of all official development assistance targets remains crucial and recall the respective commitment of many developed countries to official development assistance, including 0.7 per cent of gross national income provided as official development assistance, with 0.15 to 0.2 per cent allocated to least developed countries


    Underscore the importance of enhanced international cooperation to support efforts of Member States to achieve health goals, including the target of ending the AIDS epidemic by 2030, implement universal access to health-care services and address health challenges


    Tailoring HIV combination prevention approaches to meet the diverse needs of key populations, including among sex workers, men who have sex with men, people who inject drugs, transgender people, people in prisons and other closed settings and all people living with HIV


    Commit to prioritize HIV prevention and to ensure by 2025 that 95 percent of people at risk of HIV infection, within all epidemiologically relevant groups, age groups and geographic settings, have access to and use appropriate, prioritized, person-centred and effective combination prevention options 


    (a) Increasing national leadership, resource allocation and other evidence- based enabling measures for proven HIV combination prevention, including condom promotion and distribution, pre-exposure prophylaxis, post-exposure prophylaxis, voluntary male medical circumcision, harm reduction, in accordance with national legislation, sexual and reproductive health-care services, including screening and treatment of sexually transmitted infections, enabling legal and policy environments, full access to comprehensive information and education, in and out of school; 


    (b) Tailoring HIV combination prevention approaches to meet the diverse needs of key populations, including among sex workers, men who have sex with men, people who inject drugs, transgender people, people in prisons and other closed settings and all people living with HIV; 


    (c) Ensuring the availability of pre-exposure prophylaxis for people at substantial risk of HIV and post-exposure prophylaxis for people recently exposed to HIV by 2025

    1. d) Using national epidemiological data to identify other priority populations who are at higher risk of exposure to HIV and work with them to design and deliver comprehensive HIV prevention services; these populations may include women and adolescent girls and their male partners, young people, children, persons with disabilities, ethnic and racial minorities, indigenous peoples, local communities, people living in poverty, migrants, refugees, internally displaced persons, men and women in uniform and people in humanitarian emergencies and conflict and post-conflict situations;


    1. g) Committing to accelerating efforts to scale up scientifically accurate, age- appropriate comprehensive education, relevant to cultural contexts, that provides adolescent girls and boys and young women and men, in and out of school, consistent with their evolving capacities, with information on sexual and reproductive health and HIV prevention, gender equality and women’s empowerment, human rights, physical, psychological and pubertal development and power in relationships between women and men, to enable them to build self-esteem and informed decision-making, communication and risk reduction skills and develop respectful relationships, in full partnership with young persons, parents, legal guardians, caregivers, educators and health-care providers, in order to enable them to protect themselves from HIV infection; 


    (h) Considering removing structural barriers and spousal consent requirements for sexual and reproductive healthcare services and HIV prevention, testing and treatment services; (i) Conducting public awareness campaigns and targeted HIV education to raise public awareness about HIV;


    Commit to achieve the 95–95–95 testing, treatment and viral suppression targets within all demographics and groups and geographic settings, including children and adolescents living with HIV, ensuring that, by 2025, at least 34 million people living with HIV have access to medicines, treatment and diagnostics 


    (a) Establishing differentiated HIV testing strategies that utilize multiple effective HIV testing technologies and approaches, including point-of-care early infant diagnosis and HIV self-testing, and rapidly initiate people on treatment shortly after diagnosis; 


    (b) Using differentiated service delivery models for testing and treatment, including digital, community-led and community-based services that overcome challenges such as those created by the COVID-19 pandemic by delivering treatment and related support services to the people in greatest need where they are; 


    (c) Achieving equitable and reliable access to safe, affordable, efficacious high-quality medicines, diagnostics, health commodities and technologies by accelerating their development and market entry, reducing costs, strengthening local development, manufacturing and distribution capacity, including through aligning trade rules and global trade that facilitates public health objectives, as well as encouraging the development of regional markets;


     (d) Making HIV viral load testing and monitoring regularly available to all persons receiving HIV treatment at appropriate time intervals, as recommended by the World Health Organization, including through the use of pointof-care viral load testing to deliver results by the end of their clinical visits;


    (e) Ensuring that the needs of older persons living with HIV are met through the provision of available, acceptable, accessible, equitable, affordable and quality health care, and related services, free from stigma and discrimination, that support independence and social interaction, health and well-being, including mental health and well-being


    Commit to the Greater Involvement of People Living with HIV/AIDS principle and to empower communities of people living with, at risk of and affected by HIV, including women, adolescents and young people


    Expanding investment in societal enablers – including protection of human rights, reduction of stigma and discrimination and law reform, where appropriate – in lowand middle-income countries to 3.1 billion United States dollars by 2025;


    Working towards the vision of zero stigma toward and discrimination against people living with, at risk of and affected by HIV, by ensuring that less than 10 per cent experience stigma and discrimination by 2025, including by leveraging the potential of Undetectable = Untransmittable;


    Ensuring political leadership at the highest level to eliminate all forms of HIV-related stigma and discrimination, including by promoting greater policy coherence and coordinated action through whole-ofgovernment, whole-of-society and multisectoral response;


    Ensuring that all services are designed and delivered without stigma and discrimination, and with full respect for the rights to privacy, confidentiality and informed consent


    Mobilizing additional sustainable domestic resources for HIV responses through a wide range of strategies and approaches, including public-private partnerships, debt financing, debt relief, debt restructuring and sound debt management, progressive taxation, tackling corruption and ending illicit financial flows, identifying, freezing and recovering stolen assets and returning them to their countries of origin, and ensuring progressive integration of financing for HIV responses within domestic financing for health, social protection, emergency responses and pandemic responses.

  • ---------------------------------------------------

    What does the UNAIDS Global Strategy 2021-2026 say about HIV Prevention Combination (PrEP, HIV Self-Testing, TasP/U=U) in relation to key populations?







    Result Area 1:

    Primary HIV prevention for key populations, adolescents and other priority populations, including adolescents and young women and men in locations with high HIV incidence


    HIV prevention efforts are not currently having the impact needed to end AIDS. The estimated 1.7 million people who newly acquired HIV in 2019 far exceeded the 2020 target of fewer than 500 000 new HIV infections. Insufficient resources and inadequate focus on preventing new HIV infections among key populations and their sexual partners and adolescent girls and young women in sub-Saharan Africa are the biggest reasons for the slow progress. The risk of HIV transmission among key populations and their sexual partners is the major contributor to new HIV infections globally and in every region outside of eastern and southern Africa. Although the likelihood of key populations acquiring HIV exceeds the risk among other populations, the gaps in HIV investment are disproportionately large for HIV prevention among key populations. HIV prevention efforts have also been slow to address how harmful alcohol or non-injecting drug use, such as “chemsex” and the use of other stimulant drugs that affect sexual behaviours and increase risks of HIV acquisition.

    Political commitment and resources for evidence- and rights-based combination HIV prevention remains inadequate, and harmful social norms, stigma, discrimination and punitive laws still obstruct prevention efforts. Key populations continue to face these and other barriers to access HIV prevention services. Even though people in key populations are at a much greater risk of acquiring HIV, investments in HIV prevention for key populations are disproportionately low.

    There are important opportunities to strengthen and transform HIV prevention efforts, including primary prevention, over the next five years and reduce the inequalities in access to HIV prevention. The new Strategy prioritizes the implementation and scale-up of evidence informed, rights-based, community-led combination prevention packages that are tailored to address the diverse needs, circumstances and preferences of the populations who need effective prevention the most and that can yield the greatest programmatic impact.


    Strategic Priority Action:

    Expand and promote equitable, affordable access to high-quality medicines, health commodities, science, technology, innovations and solutions for people living with hiv, key populations and other priority populations.


    • Optimizing quality of life and well-being across the life-course, through integrated, people-centred services
    • People-centred approaches enable individuals to receive the holistic, coordinated services they need in convenient, respectful and efficient ways. Integrating HIV and other health services is crucial to provide peoplecentred, outcomes-focused, coordinated care across the life-course. The populations most affected by inequalities in the HIV response are often least likely to receive integrated service packages that are designed to meet their needs
    • Although many people could benefit from service integration, critical intersecting inequalities and integration gaps undermine HIV, health, well-being and quality-of-life outcomes for people living with HIV
    • Similarly, women living with HIV are six times more likely to experience invasive cervical cancer and are more likely than HIV-negative women to die of cervical cancer even when receiving ART. Yet services for prevention, screening and treatment of cervical cancer are insufficiently integrated with HIV services and typically are not available at scale. Mental health, treatment services for drug and substance use, and services for the prevention and treatment of hepatitis C are rarely integrated and linked with HIV services, notwithstanding the high prevalence of HIV among people who use drugs, particularly people who inject drugs





    • For people living with and at risk of HIV across the life course, promote and intensify comprehensive, integrated health and social services, community engagement for peer support and addressing stigma and discrimination, including linkages between HIV services and support services for other communicable and noncommunicable diseases, mental health, alcohol, drug use and substance dependence, and services for sexual and reproductive health, genderbased violence, harm reduction and mental health.
    • Expand rights-based community contact-tracing and scale up access to the latest technologies for TB screening, diagnosis, treatment and prevention for people living with HIV and ensure optimal linkages to HIV care.
    • Scale up integrated services for HIV, syphilis, viral hepatitis, sexually transmitted infections and other infections in antenatal and postnatal services and other settings, where needed.
    • Leverage both HIV and broader health investments to transform data recording and reporting systems of vertical programmes and adapt integrated health data systems (including with other sectors such as social welfare and protection) to identify gaps, barriers and solutions to achieve effective integrated health services for people living with HIV and at risk of HIV.





    Result Area 4:

    Fully recognized, empowered, resourced and integrated community-led HIV responses for a transformative and sustainable HIV response


    If we are to reduce HIV-related inequalities and get the response on-track to end AIDS by 2030, communities living with or affected by HIV must lead the way. Communities living with and affected by HIV have been the backbone of the HIV response at every level, from global to national to community. They advocate for effective action; they inform local, national, regional and international responses regarding communities’ needs; and they plan, design and deliver services. They also advance the realization of human rights and gender equality, and support the accountability and monitoring of HIV responses. Communities give voice to people who are often excluded from decision-making processes. Effective community-led HIV responses must be adequately resourced and supported to enable communities to play their vital roles as equal, fully-integrated partners in national systems for health and social services.

    As seen during COVID-19 pandemic, under-utilization of the potential of communities is compounded by an acute shortage of resources for community-led responses. Shrinking space for civil society in many countries, as well as persistent social and structural factors, exacerbate the pressures on community-led HIV responses and increase the risk of violence against organizations that serve key populations or other marginalized groups.

    Reducing inequalities in the response will require the robust resourcing, engagement, capacity building and leadership of community-led responses. The false dichotomy between government-led health system responses and community-led health system responses must be transcended in national systems for health and social services, with communities fully integrated as essential partners in each and every aspect of the HIV response.


    Priority Action



    • Support community-led monitoring and research and ensure that community generated data is used to tailor responses to the needs of people living with HIV and key populations, including young key populations.
    • Scale up community-led service delivery to ensure that the majority of HIV prevention programmes are led by key populations, women and young people, and that all HIV testing, treatment and care programmes include community-led elements
    • Integrate community-led HIV responses into all national HIV responses. Ensure urgent PRIORITY ACTIONS TO ACHIEVE TARGETS AND RESULTS: and adequate support for community-led responses at scale in all countries, especially those transitioning to domestic funding, in conflict zones and during humanitarian crises.
    • Mobilize funding for sustainable community-led responses, ensuring financial support and equitable pay for community-led work and funding for activities led by networks of people living with HIV and key populations, including those led by women and young people.


    Result Area 5:

    People living with HIV, key populations and people at risk of HIV enjoy human rights, equality and dignity, free of stigma and discrimination


    Stigma, discrimination and other human rights violations in the context of HIV both reflect and drive the inequalities that undermine HIV responses. Everyone, including people living with and affected by HIV, should enjoy human rights, equality and dignity. The goal of zero discrimination still eludes the world. In 25 of 36 countries with recent data, more than 50% of people aged 15–49 years displayed discriminatory attitudes towards people living with HIV.

    Denial of health services to people living with HIV remains distressingly common, and the prevalence and effects of discrimination are often especially acute for members of key populations, who face multiple, overlapping forms of discrimination.

    Efforts to anchor HIV responses in human rights principles and approaches, including the priority actions outlined below, can only be achieved through strong political leadership and the active engagement and leadership of community-led responses that are adequately resourced to advocate for, monitor and implement rights-based responses. In working towards the goal of zero discrimination, important progress needs to be continued, accelerated, scaled up and funded. Stigmatizing attitudes have declined notably in numerous countries, and U=U has the potential to accelerate anti-stigma efforts.







    Result Area 8:

    Fully funded and efficient HIV response implemented to achieve the 2025 targets


    The inequalities that are slowing progress in the HIV response have increased the resource needs for the global response and have underscored the urgent need for sustainable HIV financing. Additional resources will be needed to reduce inequalities, account for deficits resulting from the failure to achieve the Fast-Track targets, close service gaps resulting from the COVID-19 pandemic and to put the world on-track to end AIDS by 2030.

    HIV must remain a priority for health systems and financing, including to support Universal Health Coverage and achievement of the relevant SDGs. In working to mobilize robust, sustainable financing, there are important opportunities that must be seized. In light of the demonstrated value of HIV infrastructure for national COVID-19 responses, the HIV response should showcase how HIV investments build capacity, strengthen programme infrastructure, support pandemic preparedness and create platforms to address other health conditions, including noncommunicable diseases.

    Domestic financing accounts for approximately 56% of available financing for the global HIV response. Although domestic financing overall has not increased quickly enough, domestic HIV investments in 2015–2019 rose substantially in several countries. That trend, while promising, masks disparities in funding allocation.

    The negative economic impact of the COVID-19 pandemic has created additional challenges for many low- and middle-income countries to mobilize new domestic resources for their HIV responses. Declines in tax revenues and increases in government spending have resulted in higher debt and deficit levels, adding to existing unsustainable levels of debt in over 30 low-income countries. Several high burden countries now face the dual challenge of AIDS and COVID-19, while high levels of debt servicing significantly reduce their fiscal space to invest in their health and social sectors.

    Financing for domestic HIV responses must leverage traditional and new partnerships to meet the challenging macrofiscal environment, resist a new era of austerity and identify a range of methods for mobilizing domestic and market resources. The Strategy calls for reforms that broaden the vision of financing for HIV and health financing to promote sustainability through addressing the structural drivers of inequality, promoting progressive taxation and Universal Health Coverage, and increased social spending.


    Priority Action



    Mobilize the political leadership and global solidarity needed to secure the resources needed to get the response on-track to end AIDS as a public health threat and to realize the right to health, by taking actions to:

    • enable increased efficiency, equitable and inclusive governance, policies and delivery platforms to achieve the Strategy’s targets and sustain the gains made to date in the HIV response, and ensure affected communities and key populations are at the forefront of the decision-making processes;
    • expand partnerships to address the structural and macroeconomic barriers to increased domestic public spending in HIV and in health as societal and economic priorities;
    • maintain and increase donor funding, including for addressing the root causes of inequalities through community-led responses, particularly for low-income countries with limited fiscal ability, and for key population- and community-led responses, including in middleand upper-middle income countries;
    • mobilize political and advocacy support for the next Global Fund replenishment in 2022, and secure continued global solidarity for global, multilateral and bilateral, and domestic, funding for the AIDS response;
    • promote and increase the volume and predictability of long-term, direct funding for community-led responses, including through establishing funding earmarks across countries and public funding of community-led responses; and
    • promote increased domestic and international investments in the public sector, management processes, greater transparency and accountability, and reset public-private partnerships towards equitable outcomes.


    Develop and implement contexts pecific sustainability financing strategies (including multisectoral contributions to HIV responses) that ensure universal access and improved health outcomes, by taking actions to:

    • implement country-tailored financing frameworks that raise domestic revenues for the HIV response and social spending, increase the quality and coverage of HIV and health services, and improve resilience and sustainability of financing;
    • ensure that financing, governance and social financing frameworks for Universal Health Coverage drive progress towards HIV targets, removing structural barriers and reducing inequalities; progress should be measured by the integration of the full range of HIV prevention, treatment and care services, reaching all populations with stigma free services, and public financing of community-led responses;
    • abolish user fees for HIVrelated and other health-care services, starting with the most marginalized populations, women, girls, people living with HIV, key populations and other priority populations;
    • build on the platforms and structures of the HIV response to promote Universal Health Coverage that includes gender and other equity considerations beyond socioeconomic status and income towards realization of people’s right to health;
    • shift towards progressive health financing that provides Universal Health Coverage for the full range of HIV services, inclusion in national schemes and general tax contributions for resource pooling, and shifts away from voluntary or contributory schemes that are linked to benefit entitlements;

    implement transition strategies and plans that ensure sustainable financing, engage with communities, donors and partners to identify country-tailored solutions, and secure sustainable funding for programmes for key populations


    Result Area 9:

    Integrated systems for health and social protection schemes that support wellness, livelihood and enabling environments for people living with, at risk of and affected by HIV to reduce inequalities and allow them to live and thrive


    Existing health services often fail to address the HIV-related and other needs of people who need them most, due to discriminative attitudes or lack of sensitivity to the needs of key populations and priority populations and system capacity deficiencies. Dedicated HIV services do not always meet the broader health needs of people living with or affected by HIV.

    When integrated service packages are tailored and delivered in ways that place people at the centre, they can help rapidly reduce inequalities in the HIV response as well as support Universal Health Coverage. Peoplecentered systems for health must ensure that health and community systems, and social and structural enablers optimize the impact and sustainability of HIV programmes. This can be achieved through inclusive governance structures that draw on community knowledge and perspectives. It also calls for a full range of health services to be integrated in primary health-care settings, with special consideration to acceptability for marginalized and other populations who experience stigma and discrimination.




    • Integrate HIV into systems for health and ensure that the integrated approaches are comprehensive, peoplecentred (with integrated and fully resourced community-led responses and systems) and gender-transformative and that they reduce inequalities and uphold people’s right to health.
    • Build on experiences in the HIV response to transform health services to be people-centered, rights-based and contextresponsive, and systematically eliminate the multiple, intersecting forms of stigma and discrimination experienced by people when accessing services
    • Support community-led responses and inclusive HIV and health governance as a central Strategy to improve service provision. Integrate communityled responses to strengthen national systems for health and social services at all levels. Place emphasis on investments in community-led differentiated service delivery to ensure effective and equitable access that meets the context-specific needs of particular groups, places and individuals based on evidence of what works.


    Robust, people-centred social protection has a key role to play in reducing the intersecting inequalities that slow progress towards ending AIDS and enhancing the well-being, human dignity and productivity of households affected by HIV. Social protection reduces vulnerability, systematically removes barriers to service utilization and improves health, well-being, quality of life, enables food security and nutrition and social inclusion. All people living with and affected by HIV have an equal right to social protection, which must be mandated in national policy, legal and programmatic frameworks. These can include access to universal health services, social safety net transfers, insurance and pension benefits, and other state-facilitated systems that are available to the population. Countries are failing to ensure ready access to the social protection that people living with and vulnerable to HIV infection need. Only 29% of the world’s population has access to adequate social protection coverage; two thirds of children have no social protection coverage, and key populations are recognized as social protection beneficiaries in only 26 countries. Women and girls continue to bear the brunt of unpaid care work in the context of HIV.

    Pandemics such as AIDS and COVID-19 highlight the pivotal role of social protection in addressing and mitigating the impact of health crises. Countries have expanded or started hundreds of new social assistance interventions in response to the COVID-19 pandemic and national expenditure levels for social protection have more than tripled. Many of these actions also help mitigate the impact of HIV and TB, reduce HIV risk and enhance access to HIV and TB services. In eastern and southern African countries, where health systems are fragile and overburdened, grassroots women’s organizations have often filled gaps in formal services by helping to deliver antiretroviral and other medicines, sanitary pads, personal protective equipment, COVID-19 information, food, and cash support to individuals and families in need.


    Priority Actions



    • Conduct demand-driven assessments, operational research, monitoring and quality evaluations of existing social protection schemes and programmes and ensure that they cover people living with and affected by HIV.
    • Scale up intersectoral linkages to poverty reduction platforms and cofinancing for people living with HIV, key populations and priority populations to inclusive social protection programmes, including programmes that address the issue of unpaid care work performed by women and girls in the context of HIV.
    • Strengthen the capacity of communities affected by HIV to participate in the governance of social protection systems and deliver complementary community-led social protection services. Ensure that existing social protection initiatives, such as the social protection floors, address the needs of people living with, at risk of and affected by HIV



    Result Area 10:

    Fully prepared and resilient HIV response that protects people living with, at risk of and affected by HIV in humanitarian settings and from the adverse impacts of current and future pandemics and other shocks


    Reducing inequalities demands focused efforts to meet the needs of people who are most vulnerable and underserved, recognizing that people living with HIV and key populations in emergency and humanitarian settings are highly vulnerable to the socioeconomic impact of emergencies. They typically are least protected by national social safety nets and often experience multilayered inequalities which heighten their vulnerability. The Strategy calls for equal access to HIV services for people living with and affected by HIV in humanitarian emergencies (including refugees and internally displaced persons) and for ensuring that their health, food, nutrition, shelter and water basic needs are covered in humanitarian responses.


    Priority Actions



    • Promote policy, frameworks and legislation that ensure national emergency response plans are tailored to specific contexts and that provide the initial minimum package and expansion to comprehensive HIV services to all people affected by humanitarian emergencies who are living with HIV or at risk of HIV, regardless of residency or legal status.
    • Integrate refugees, internally displaced and other humanitarian affected populations into national HIV policy frameworks, programmes and funding proposals, reflecting their diverse needs, including support and scale-up of community-led responses and adapted service delivery
    • Resource community-led responses and scale up the engagement of communities in developing emergency preparedness plans at national and subnational levels and in providing outreach, peer support and linkages to HIV programmes.
    • Ensure granular, targeted, and adapted HIV and related programming that is based on improved surveillance, localized assessment of risks and vulnerabilities, access to services and outcomes, and strengthened community-based monitoring systems.
    • Leverage and continuously adapt existing data collection approaches to respond to different project needs, contexts or sectors in order to monitor and better support people living with HIV in fragile and humanitarian contexts.


    Given the profound and continuing effects of the COVID-19 pandemic, urgent efforts will be needed to enable HIV services and broader responses to build back better, address the vulnerabilities associated with COVID-19 (including increased incidence of gender-based violence), close pandemic related deficits and gaps, and recover momentum. In addition, the HIV response must protect people living with and affected by HIV from future unexpected challenges, such as a resurgence of COVID-19, other pandemics and financial crises.

    Specific steps are needed to ensure that all people living with HIV, key populations and other people at risk of HIV are better protected in health emergencies (based on SDG indicator 3.d.1. International Health Regulations capacity and health emergency preparedness) and have access to health and other support services. Lessons from the HIV and COVID-19 responses should be used to strengthen preparedness.




    The COVID-19 pandemic and its impact on countries and communities afford governments and partners the opportunity to “build back better”— creating systems and approaches that are more resilient and that place people and communities at the centre. As leaders make political choices during the recovery from COVID-19, it is important that gains made in the HIV response are not just sustained but enhanced. Renewed political will and leadership is needed at every level to implement this Strategy in order to reduce inequalities by 2025 and accelerate progress towards ending the AIDS epidemic by 2030. Strengthened leadership is needed to reinforce and advance the principles, targets and commitments in this Strategy as well as those made by all UN Member States in the 2030 Agenda for Sustainable Development and other political declarations

    To close the gaps in its HIV response, Asia and the Pacific should build on and replicate more broadly the important AIDS leadership that is evident in some countries. That leadership has facilitated successful and diverse models of differentiated HIV service delivery, including HIV self-testing, multimonth dispensing of antiretroviral regimens and key population-led health services that bridge gaps in traditional programming. It has also increased adoption of innovative approaches such as telehealth, take-home opioid substitution therapy, needle-syringe services and PrEP services, and it has built highly multisectoral response that capitalize on the strengths of civil society and other partners.


    1. Renew and intensify the focus on key populations in policies and programmes. Urgent, focused action is needed to bridge the significant prevention, testing and treatment service gaps for key populations, including adolescent and young key populations, through inclusive, youth-centered and gender-responsive approaches, adopting innovative strategies (including digital and virtual space interventions to reach unreached key populations), and enhancing civil society and community engagement.
    2. Modernize HIV service delivery. Priority must be given to scaling up combination prevention programmes for and led by key populations, including PrEP, self-testing, same-day ART and multimonth dispensing. Key population-led services must be prioritized, enabled and brought to scale. Adopting differentiated service delivery modalities involving nontraditional partners will allow for the integration of key population-led health services and reduce access barriers, tackle inequities, stigma and discrimination.
    3. Eliminating the barriers to equitable programme coverage among the most marginalized communities will require countries to recognize and address overlapping vulnerabilities. Concerted efforts are needed to address human rights issues in the context of HIV, promote gender equality and women’s empowerment and eliminate stigma and discrimination against key populations and people living with HIV, to identify and overcome barriers to services (including economic barriers), and to recognize and respond to gender-based violence against key populations and women and girls. Improving effectiveness and reducing inequalities also requires improved data disaggregation by age, gender, disability status, socioeconomic status and more. Law and policy reforms, including decriminalization of key populations, will be essential.
    4. Mobilize sustainable domestic financing for prevention. Domestic funding will be essential if HIV programmes are to be fully funded, including for key population-led and women- and youth-led health services under Universal Health Coverage. Domestic funding must cover expanded prevention programmes in order to achieve adequate national coverage among key populations in all settings.
    5. Commit to providing community-led responses with the resources and support they need to fulfil their role and potential as key partners in the HIV response 30% of testing and treatment services to be delivered by community-led organizations, with focus on: enhanced access to testing, linkage to treatment, adherence and retention support, treatment literacy, and components of differentiated service delivery, e.g. distribution of ARV (antiretroviral treatments) 34 80% of service delivery for HIV prevention programmes for key populations to be delivered by community-led organizations35 80% services for women, including prevention services for women at increased risk to acquire HIV, as well as programmes and services for access to HIV testing, linkage to treatment (ART), adherence and retention support, reduction/elimination of violence against women, reduction/elimination of HIV related stigma and discrimination among women, legal literacy and legal services specific for women-related issues, to be delivered by community-led organizations that are women-led. 60% of the programmes supporting the achievement of societal enablers, including programmes to reduce/eliminate HIV-related stigma and discrimination, advocacy to promote enabling legal environments, programmes for legal literacy and linkages to legal support, and reduction/elimination of gender-based violence, to be delivered by community-led organizations.